September 30, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Cure Pharmaceutical looks to acquire Coeptis Pharmaceuticals

IN THIS ARTICLE

Oxnard cannabis technology company Cure Pharmaceutical announced an initial bid to acquire Coeptis Pharmaceuticals, a maker of arthritis and high blood pressure treatments. Cure, which makes a thin dissolvable strip for oral drug delivery, announced Nov. 14 that it had purchased $200,000 in convertible promissory notes for Coeptis, a first step in a bid to…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.